A Study to Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy Adults
Clinical trial NCT06601192 · COMPLETED
Trial details
- NCT number
- NCT06601192
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-15
- Primary completion
- 2025-02-02
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.